For more c3f6information, please contact us. We will provide professional answers.
The US Environmental Protection Agency has ordered several chemical companies to test hexafluoropropylene oxide (HFPO) for possible adverse health effects.
HFPO may present an unreasonable risk of injury to health or the environment, the agency says in a statement explaining the rationale for its Jan. 4 order. The substance could cause toxicity to the nervous system, adverse reproductive effects, and cancer, according to the EPA. In addition, there is insufficient data to determine whether or how breathing HFPO, which is a gas at room temperature, affects human health, the agency adds.
HFPO is part of the family of per- and polyfluoroalkyl substances (PFAS), synthetic chemicals that are highly persistent. Some are toxic. More than 450,000 kg of HFPO are manufactured in the US each year, according to the EPA.
The information EPA receives under this order will not only improve the Agencys understanding of human health effects of HFPO, but also the effects of dozens of PFAS that are structurally similar to HFPO, the agency says in its statement.
Companies named in the order are Chemours, 3M, and both DuPont De Nemours and its predecessor company, E. I. du Pont de Nemours and Co. The EPA says the companies already voluntarily submitted some data on HFPO.
HFPO is used to make fluoropolymers, agrochemicals, and pharmaceuticals, according to the Chemours website. It is one of the substances in the companys GenX process, which replaced one of the toxic PFAS, perfluorooctanoic acid (PFOA), in the production of fluoropolymers.
The order is the second on PFAS that the EPA has issued under the Toxic Substances Control Act in accordance with the agencys strategy for testing PFAS. The first addressed 6:2 fluorotelomer sulfonamide betaine (6:2 FTAB), which is an ingredient in firefighting foams.
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/
The shallow RNA-Seq datasets generated and analyzed during the current study are available in NCBIs Gene Expression Omnibus and are accessible through GEO Series accession number {"type":"entrez-geo","attrs":{"text":"GSE","term_id":""}}GSE (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= {"type":"entrez-geo","attrs":{"text":"GSE","term_id":""}}GSE ). All datasets used and analyzed during the current study are available from the corresponding author upon reasonable request.
Hexafluoropropylene oxide-dimer acid (HFPO-DA) is one of the emerging replacements for the forever carcinogenic and toxic long-chain PFAS. HFPO-DA is a polymerization aid used for manufacturing fluoropolymers, whose global distribution and undetermined toxic properties are a concern regarding human and ecological health. To assess embryotoxic potential, zebrafish embryos were exposed to HFPO-DA at concentrations of 0.520,000 mg/L at 24-, 48-, and 72-h post-fertilization (hpf). Heart rate increased significantly in embryos exposed to 2 mg/L and 10 mg/L HFPO-DA across all time points. Spinal deformities and edema phenotypes were evident among embryos exposed to 16,000 mg/L HFPO-DA at 72 hpf. A median lethal concentration (LC 50 ) was derived as mg/L at 72 hpf. Shallow RNA sequencing analysis of transcripts identified 38 consistently differentially expressed genes at 0.5 mg/L, 1 mg/L, 2 mg/L, and 10 mg/L HFPO-DA exposures. Notably, seven downregulated genes were associated with visual response, and seven upregulated genes were expressed in or regulated the cardiovascular system. This study identifies biological targets and molecular pathways affected during animal development by an emerging, potentially problematic, and ubiquitous industrial chemical.
Gene expression changes during organogenesis, fetal, and infantile development due to chemical exposures can increase susceptibility to disease later in life (Grandjean et al. ; Pennings et al. ; Peterson et al. ), demonstrating how environmental exposure to HFPO-DA may affect embryogenesis. Danio rerio (zebrafish) is a well-established human disease, genetics, embryology, and physiology model organism (Lieschke and Currie ), whose genome (Howe et al. ) has at least one ortholog of 71.4% of human genes and 82% of human disease-related genes. Its sensitivity to chemicals (von Hellfeld et al. ), compatibility with mammalian system toxicity assessment (Ducharme et al. ), and well-studied development (Kimmel et al. ) allow for robust assessments of toxicological developmental phenotypes. The goal of our study is to characterize the in vivo toxicity potential of HFPO-DA by evaluating adverse physiological effects at acute exposure levels and determining molecular targets of HFPO-DA exposures. We identified adverse acute exposure effects on morphological and physiological phenotypes, and gene expression alterations via shallow RNA sequencing during zebrafish early development.
Since increasing PFAS chain length is associated with biological and chemical stability and toxicity (Hagenaars et al. ; Jantzen et al. ), long-chain PFOA was succeeded by shorter-chain, potentially less toxic, and less bioaccumulative variants. Hexafluoropropylene oxide-dimer acid (HFPO-DA, C 6 HF 11 O 3 ), commonly referred to as GenX, is a short-chain polymer processing aid used as an alternative to PFOA to make fluoropolymers (Brandsma et al. ; US EPA a ). Having six-carbon atoms and an ether group (Supplementary Table S1 ) is supposedly less toxic than the eight-carbon PFOA; it is environmentally persistent (Beekman et al. ), highly stable, and water-soluble (Hassell et al. ; Liberatore et al. ), with a half-life of 20 h in mice (Gannon et al. ) compared to approximately h for PFOS (Chang et al. ). US EPA derived a final lifetime health advisory level in drinking water as 10 ng/L (US EPA c ). Cape Fear River, NC, US, a drinking water source, was reportedly contaminated by a nearby manufacturer and contained up to ng/L HFPO-DA in (Sun et al. ). HFPO-DA was the largest proportion of PFAS in all surface water samples along the German coastline at a mean concentration of 1.6 ng/L in (Joerss et al. ) and was detected in 90% of surface water samples at a mean concentration of 30 pg/L in the Arctic Ocean and its neighboring waterbodies in (Joerss et al. ). In , rain and well-water assays in Ohio and Indiana detected HFPO-DA in six sites at 0.25 ng/L (Galloway et al. ). Evidence for HFPO-DA hepatotoxicity (Conley et al. ; Shi et al. ), and metabolic (Conley et al. ) and endocrine disruption (Xin et al. ), the risk of both acute and chronic environmental exposures, and a lack of human-health exposure data, necessitate comprehensive toxicological and ecological risk assessment.
Per- and polyfluoroalkyl substances (PFAS) represent a diverse group of over chemicals that contain carbonfluorine bonds, the strongest chemical bond in organic chemistry. PFAS (Supplementary Table S1 ) are widely used in many industrial and consumer products including waterproof and non-stick items, such as pans, food wrappers, waterproof fabrics, lubricants, surfactants, chemically inert composites, insulators, firefighting foams, and plastics (Beekman et al. ; US EPA b ; L. H. Yang et al. ). The strength of the carbonfluorine bond makes most PFAS resistant to degradation and persistent in the environment. PFAS exposures have been associated with adverse health effects in animals, including cancer (Barry et al. ; Biege et al. ; Shearer et al. ; Vieira et al. ), endocrine disruption (Dhillon et al. ; Du et al. ), hepatotoxicity (K. Li et al. ), immunotoxicity (Dewitt et al. ), and developmental and reproductive toxicity (Conley et al. ; Salimi et al. ). The ubiquitous environmental presence of PFAS prompted the implementation of the Environmental Protection Agency PFOA Stewardship Program in , requiring major fluoropolymer manufacturers to reduce or eliminate emissions of perfluorooctanoic acid (PFOA, C 8 HF 15 O 2 ) and related chemicals (US EPA ). In , PFAS were detected in over 97% of screened human serum samples (Lewis et al. ; US CDC ). The primary route of human exposure is through water (Franke et al. ); in , drinking water supplies for six million Americans exceeded the United States Environmental Protection Agencys (US EPA) PFOS and PFOA lifetime health advisory level of 70 ng/L, which has been updated to 0.02 ng/L and 0.004 ng/L, respectively (Hu et al. ; US EPA c ).
Pairwise differential gene expression was determined using the noiseqbio function of NOISeq (version 2.14.1), with the thresholds q > 0.9 and FDR < 0.1 (Tarazona et al. ). Agglomerative hierarchical clustering was performed using Wards method in the R package cluster (Maechler et al. ). Enrichment in Gene Ontology (GO, Open Biological Ontologies Foundation) biological process terms was quantified via the Cytoscape plugin BiNGO (version 3.0.5) using total zebrafish genome annotation as background (hypergeometric test, BenjaminiHochberg p < 0.05) (Maere et al. ). Figures were generated using R (version 4.1.2) packages ComplexHeatmap (Gu et al. ) and GOplot (Walter et al. ).
Data normality for embryo survival, morphology, and HBPM was evaluated using ShapiroWilk (p < 0.05), and equal variance was tested using the Brown-Forsythe method (p < 0.05). Survival, HBPM, and morphometric measurements between exposure groups were analyzed by one-way ANOVA with Tukeys HSD if data were normal and equally variable. Nonparametric data were analyzed with a KruskalWallis ANOVA with Dunns multiple comparisons for equal variances, or SteelDwass multiple comparisons for unequal variance. Doseresponse curves for malformations were fitted to the model with the lowest Akaike Information Criterion, p < 0.05. JMP Pro (version 14.0, SAS Institute Inc, Cary, NC, USA) was used for statistical analysis and figure generation.
Shallow RNA-Seq results were verified via qRT-PCR analysis, using statistically significant six upregulated (minimum fold change of 2.59-fold) and five downregulated (minimum fold change of 1.56-fold) genes in all exposures. actb1 was selected for housekeeping gene normalization based on its reliability (McCurley et al. ; Tang et al. ; Xu et al. ) and stable expression within and between exposures. Primers were designed using Primer-BLAST (J. Ye et al. ) with standard parameters (Supplementary Table S3 ). Equal concentrations from three shallow RNA-Seq replicates were pooled for qRT-PCR per iTaq Universal SYBR Green One-Step kit protocol (Bio-Rad, Hercules, CA, USA). qRT-PCR results were analyzed with the 2 ΔΔCt method. To compare expression values between qRT-PCR and shallow RNA-Seq, counts from shallow RNA-Seq were normalized using the transcript per million (TPM) (B. Li and Dewey ) and TMM methods relative to actb1.
Sample data were demultiplexed by Scripps Research Genomics Core using BBTools (version 37.62) (Bushnell et al. ). Raw shallow RNA-Seq data quality was assessed using FastQCR (Kassambara ), and UMIs were extracted using UMI-tools (version 1.1.2) (Smith et al. ). To remove adapters and optimize for differential expression detection, Trimmomatic (version 0.40) was used to remove the first 16 bases of each read, trim reads according to a sliding window of length 4 and minimum Phred score of 20, and to remove resulting reads shorter than 20 bases (Bolger et al. ). SortmeRNA (version 2.1) was used to filter out contaminating rRNA (Kopylova et al. ). The remaining reads were aligned to zebrafish genome assembly version 10 (GRCz10) using STAR (version 2.7.3a) (Dobin et al. ). PCR deduplication was performed using extracted UMIs via UMI-tools (Smith et al. ). Read counts per gene were quantified using HTSeq (version 0.13.5) with default settings (Putri et al. ), and transcript variants were treated as single genes. Gene expression was normalized using a trimmed mean of M values (TMM) (Robinson & Oshlack ). Differential expression analysis was performed in parallel using the noiseqbio function of NOISeq (version 2.14.1) on data filtered in increments of 0.25 from 0 to 5 CPM (Tarazona et al. ). gGenes of > 2.75 average CPM were selected for further analysis. Raw and processed shallow RNA-Seq data were deposited in the National Center for Biotechnology Information Gene Expression Omnibus under the accession {"type":"entrez-geo","attrs":{"text":"GSE","term_id":""}}GSE (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= {"type":"entrez-geo","attrs":{"text":"GSE","term_id":""}}GSE ).
Sample quality was assessed using a Bioanalyzer (Agilent Technologies) (RIN > 8.5). Library preparation was performed using the HTP RNA-Seq Library Prep Kit (iGenomX Inc, San Francisco, CA, USA). Briefly, barcoded oligo dT primers were added to 50 ng RNA per sample and reverse transcribed. Sample cDNA products were combined, cleaned, and run through PCR with 0.5 µM barcoded PCR primers (p5 and p7 sequences, Illumina, San Diego, CA, USA). Purified PCR products were sequenced using a NextSeq sequencer (paired-end mode; read1: 26 bp, read2: 94 bp), generating greater than 1.5 million paired-end reads for each sample.
Total RNA was isolated from pooled samples of 810 embryos with four pools for each exposure using the TRIzol reagent protocol (Invitrogen, Carlsbad, CA, USA). Briefly, TRIzol was added to frozen embryos, before allowing embryos to thaw. Samples were homogenized in a Bead Mill 4 (Fisher Scientific, PA) using sterile 2 mm glass beads and resuspended in 50 µL RNase-free water. The quantity and quality of samples were determined using a NanoDrop (A260/280 and A260/230 > 1.8). Between 500 and 750 ng of total RNA per sample were delivered to the Scripps Research Genomics Core (San Diego, CA, USA) for library prep and shallow RNA sequencing (RNA-Seq).
The stability of HFPO-DA concentration in water was assessed by preparing media following embryo exposures, with the exclusion of embryos. Exposure media (10 mL) was aged at 28.5 °C in an incubator and collected at 0 h, 24 h, 48 h, and 72 h with 50% water changes at 24 h and 48 h.
Instrumental analysis of standards, water, and embryo extracts was performed on an Agilent Infinity II UHPLC (Santa Clara, CA, USA) outfitted with an Agilent PFC-Free HPLC Conversion Kit. Separation was performed on an Agilent Poroshell 120 EC-C18 column and guard column, with a Restek Ultra Aqueous C18 trap column (Bellefonte, PA, USA) and Agilent Zorbax Eclipse Plus C18 delay column, under the following conditions: mobile phase A (2 mM ammonium acetate in 5:95 acetonitrile:water), mobile phase B (acetonitrile), needle/seat wash (50:50 acetonitrile:water) using two cycles of the seat back flush and needle wash (10 s each), seal wash (10:90 isopropanol:water), injection volume 5.00 µL, flow rate 0.50 mL min 1 , and solvent gradient mobile phase A; mobile phase B being initial (85%:15%), 1.00 min (85%:15%), 5.00 min (10%:90%), 6.40 min (10%:90%), and 6.50 min (85%:15%), end time 9.50 min, and column temperature 50.0 °C. The UHPLC was coupled to an Agilent C triple quadrupole mass spectrometer (MS) operated in ESI negative mode, MRM scan, gas temperature 150 °C, gas flow 8L min 1 nebulizer 45 psi, sheath gas heater 200 °C, sheath gas flow 8 L min 1 capillary V, and nozzle voltage 0 V. MRM transition was precursor ion 284.9, quantification product ion 168.9, and confirmation ion 184.9 with ion ratio of 1.95 ± 0.20. The quantification reference compound was 13 C 3 -HFPO-DA.
where C F is the average concentration of HFPO-DA in embryos, and C W is the average concentration of HFPO-DA in water at 0 h, 24 h, 48 h, and 72 h. Analysis of HFPO-DA in water and embryo samples followed modified methods (Gaballah et al. ; US EPA a ). Native and mass-labeled standards (Wellington Laboratories, Inc., ON, CA) were diluted in 95% methanol:5% aqueous 2.5 M NaOH. All standards, samples, and extracts were stored in plastic at 4 °C. Water samples were diluted in 5% acetonitrile:95% water, fortified with perfluorononanoic acid (PFNA) as a surrogate and 13 C 3 -HFPO-DA as the internal standard, and directly injected. Embryo samples were extracted by protein precipitation, pooled and subsampled to obtain three 20.0 mg replicates (~ 100 embryos), flash frozen, and homogenized using a Bead Ruptor 12 (Omni International, GA, USA) with 250 mg of zirconia/silica beads (1.0-mm dia) in 500 µL 0.1 M formic acid that was fortified with PFNA. The protein was precipitated with 500 µL acetonitrile fortified with the internal standard and centrifuged at 15,000 rpm for 15 min at 4 °C. A 50-µL aliquot of the extract was diluted with 200 µL of aqueous 0.4 mM ammonium formate.
If you want to learn more, please visit our website buy sulfur hexafluoride.
Explore more:To assess the bioaccumulative potential of HFPO-DA in zebrafish embryos, embryos were exposed to mg/L HFPO-DA at 28.5 °C until 72 hpf with 50% water changes at 24 h and 48 h. Embryos were snap-frozen at 80 °C and collected into 15 mL high-density polypropylene Falcon tubes spun down at rpm for 2 min; the excess liquid was removed, and embryo samples were re-stored at 80 °C. HFPO-DA embryo body burden analysis was performed by Statera Environmental, Inc. (Raleigh, NC, USA). Pooled embryos were collected, homogenized, and dried (total dry weight: 0.702 g, embryos in 0 mg/L; 1.026 g, embryos in mg/L), then subsampled to 3 replicates per condition. A bioconcentration factor (BCF) was calculated using the following equation (Veith et al. ):
Surviving larvae were imaged within wells or depression slides (SeBaCam, Laxco); lateral view images (40 ×) were used to identify malformations (von Hellfeld et al. ). Pericardial edema was categorized as swelling peripheral to the pericardium, and yolk-sac edema was characterized as sections of the yolk-sac that were transparent rather than pigmented and separated from the yolk-sac. Spinal deformations were qualified as curved if a line traced from eye to tip of tail deviated from 180° during any 1 mm segment aside from the head-trunk angle, or if the head-trunk angle was greater than 60°. These malformations were further categorized as kyphosis (excessive forward curve), lordosis (excessive inward curve), or scoliosis (sideways curve). The severity of malformation at 72 hpf was scored on a scale of 1 to 4, modified from the existing scoring method (Gaballah et al. ): Normally developing embryos were scored as 1, single malformation as 2, two malformations as 3, and four or greater malformations as 4. Effect concentration (EC 50 ) was calculated using a sigmoidal 4PL fit curve.
At least 50% of embryos from each exposure were randomly selected to assess heart beats per minute (HBPM) at 24 hpf, 48 hpf, and 72 hpf. Embryo plates were acclimated to room temperature for 10 min, and each embryo was placed under the microscope light for 30 s before heartbeats were counted for 30 s. Embryos at 72 hpf were then pooled into batches of 810 and snap-frozen and stored at 80 °C until RNA extraction.
Due to the high solubility of HFPO-DA, reportedly over 751 g/L (US EPA b ; Nixon and Lezotte ), exposure solutions were prepared by directly adding HFPO-DA (Undecafluoro-2-methyl-3-oxahexanoic acid, CASRN: 13,25213-6; 97% purity, Catalog No. 3-13, SynQuest; Alachua, FL, USA) to embryo water without using a vehicle. Because pH affects embryo mortality (Andrade et al. ), assays using pH-neutralized HFPO-DA (pH = 6.67.6) were performed. pH neutralization was performed by titrating with 0.765 M NaOH and 6 M HCl (Cassar et al. ; OECD ; S. Y. Williams and Renquist ) and checking with a pH meter (PH220-C, Extech Instruments, Nashua, NH, USA). Prepared exposure solutions were stored in glass bottles at 4 °C one day prior to exposure. Individual embryos in 24-well plates were exposed to 2 ml of 0.5 mg/L, 1 mg/L, 2 mg/L, 10 mg/L, mg/L, mg/L, mg/L, mg/L, 10,000 mg/L, 12,000 mg/L, 16,000 mg/L, and 20,000 mg/L titrated HFPO-DA from 3 to 4 hpf, the sphere developmental stage (Kimmel et al. ), until 72 hpf. Negative control embryos were grown in embryo water, and positive control embryos were exposed to 4 mg/L 3,4-dichloroaniline. Embryos were incubated at 28.5 °C (Precision Microbiological Incubator, Thermo Scientific, Waltham, MA, USA) throughout exposures. Fifty percent of the exposure solution in each well was refreshed daily. pH and dissolved oxygen (DO) were noted for each plate daily. Exposures were deemed valid if over 80% of negative control embryos survived and developed normally, while over 30% of positive control embryos died (OECD ). Exposure sample sizes per treatment are listed in Supplementary Table S2 .
Breeding tanks with one female and two male F1 generation zebrafish were established 24 h before embryo collection. Adults were bred for 1 h after the onset of the light cycle, and embryos were collected in Pyrex glass dishes covered with mesh; embryos were staged (Kimmel et al. ) under a stereo microscope (AmScope Compact Multi-Lens Stereo Microscope, model #SE306R-A) at 30 × magnification. Debris and abnormally developing embryos manifesting severe cleavage asymmetry, detached cytoplasm, and/or broken chorions were removed. The remaining embryos were kept at 28.5 °C (Precision Microbiological Incubator, Thermo Scientific, Waltham, MA, USA) in deionized water reconstituted with Instant Ocean® (Instant Ocean Spectrum Brands, Blacksburg, VA, USA) to 60 μg/L, adjusted to pH 6.67.6.
Adult zebrafish AB strain (Carolina Biological; Burlington, NC, USA) were acclimated to lab conditions for six months and maintained per established laboratory guidelines (Institute of Laboratory Animal Resources (US). Committee on Care and Use of Laboratory Animals, ). Ten zebrafish per liter were housed in a recirculating system in 1.3- or 3.3-L polycarbonate tanks maintained at 28.5 ± 1 °C on a 14 h light:10 h dark cycle. Adults were fed Tetramin® Tropical Flake Food (Tetra, Blacksburg, VA, USA) and brine shrimp (Brine Shrimp Direct, Ogden, UT, USA) daily. Experimental procedures, including non-surgical tissue sampling and fish embryo culturing and maintenance, were approved by the San Diego State University Institutional Animal Care and Use Committee (Animal Welfare Assurance Number A-01).
Gene ontology analysis revealed enriched biological processes in set S. Three genes, aldocb (downregulated), suclg1 (upregulated), and ugt5d1 (upregulated), are involved in metabolic processes; aldocb and suclg1 encode key proteins in cellular respiration, while ugt5d1 is involved in drug metabolism. Six downregulated genes (dpysl5b, gad1b, vat1, nsfa, lhfpl3, smarcd1) are involved in neurotransmission or neurogenesis, and ten downregulated genes (pde6hb, pde6c, prph2, gnat2, gngt2b, opn1mw1, opn1sw1, opn1sw2, syt5b, cdk5r2a, obsl1a, dio3a) are involved in eye development or the phosphodiesterase 6 (PDE6) phototransduction cascade. Seven upregulated genes (znfl2a, fbxl22, col22a1, ncf1, rplp1, rps15a, rps27.1) play a role in muscle contraction, regulation of vascular stability, or hemopoietic development. Major enrichment terms and associated DEGs are shown in Fig. .
DEGs in at least one exposure ( genes) are designated as set A (Fig. ), while DEGs shared across all four exposures are designated set S (Fig. ). Hierarchical clustering outlines seven clusters within set A and five clusters in set S (Fig. , Supplementary Tables S3 , S4 , S5 , and S6 ). Cluster A1 (349 genes, 94.3% downregulated) is enriched for genes related to perception: A subset of 11 downregulated genes forms cluster S1, which is enriched for the detection and response of abiotic, chemical, and light stimuli; another subset of 7 downregulated genes form cluster S2, which is enriched for the development of eye and nervous systems. Upregulated clusters A3 (237 genes, 85% upregulated) and S4 (8 genes, 100% upregulated) are enriched for gene expression regulation and macromolecular biosynthesis. Cluster A2 (275 genes, 98.5% upregulated) and cluster S3 (5 genes, 100% upregulated) have DEGs implicated in defense responses to fungus and respiratory burst. Cluster S5 DEGs (6 genes, 100% upregulated) regulate actin filament-based movement, cardiac muscle cell contraction, and activation of NF-kappaB-inducing kinase activity. Clusters A4 (172 genes, 95.6% upregulated), A6 (93 genes, 100% downregulated), and A7 (129 genes, 100% upregulated) were not enriched for any terms at an FDR adjusted p < 0.05.
Of genes analyzed, 16.47% ( genes) were differentially expressed in embryos exposed to 0.5 mg/L, 1 mg/L, 2 mg/L, or 10 mg/L HFPO-DA (q > 0.9, FDR < 0.1; Fig. , Supplementary Table S1 ); relative to control embryo gene expression, 41% of differentially expresses genes (DEGs) were downregulated and 59% were upregulated. Most DEGs (616 genes) were in the lowest HFPO-DA exposure of 0.5 mg/L, while the 1 mg/L exposure had the least (487 genes). The percentage of DEGs per individual exposure and percentage overlaps are presented in Fig. , and the ten highest and ten lowest expressed genes in each exposure are presented in Supplementary Fig. S2 and Table S2 .
Embryo HBPM at 72 hpf was significantly higher relative to control at the LOAEL of 2 mg/L (NO observed adverse effect level, NOAEL = 1 mg/L) and at 10 mg/L (Fig. , p < 0.01; Supplementary Table S5 ). HBPM increased during all exposure concentrations up to 10 mg/L, except for 48 hpf 0.5 mg/L. The increase in HBPM was the greatest between 0 and 10 mg/L (24 hpf: 16.75%, 48 hpf: 8.23%, 72 hpf: 8.09%). HBPM decreased most at mg/L (mean ± SD, 24 hpf: 55.55 ± 12.03, 48 hpf: 119.73 ± 27.82, 72 hpf: 146 ± 157.15 HBPM) relative to controls (p < 0.01; Supplementary Table S6 ).
Malformations identified in the 16,000 mg/L exposures range increased in severity with increasing exposure concentration (Fig. , Supplementary Table S2 ), with the lowest observed adverse effect level (LOAEL) at mg/L (p < 0.001). The half-maximal effective concentration (EC 50 ) was mg/L (95% CI = 11,179 mg/L). Stunted growth (Fig. .f, 16,000 mg/L) was marked by spinal deformations, including kyphosis (Fig. .o, 16,000 mg/L), scoliosis (Fig. .u, 16,000 mg/L), lordosis (Fig. .v, 16,000 mg/L), and tail kinks (Fig. .k, 16,000 mg/L). Other malformation phenotypes were pericardial edema and hemorrhage (Fig. .n, 10,000 mg/L) and yolk-sac edema (Fig. .q, 10,000 mg/L). Forty-six percent of embryos exposed to 16,000 mg/L HFPO-DA manifested spinal deformations, while edemas/hemorrhaging were apparent in 21.2% of embryos.
This study assessed the toxicity potential of the emerging PFAS HFPO-DA during animal development. High concentrations of HFPO-DA exposures resulted in morphological changes, including scoliosis and edema at lethal HFPO-DA concentrations, increases in HBPM, and significant gene expression changes in visual and cardiovascular systems at sublethal concentrations among zebrafish embryos assayed from 3 to 72 hpf. Data were derived from pH-neutralized HFPO-DA exposures to avoid confounding effects of acid toxicity; the pH of exposure media was not discussed in prior studies, which may explain variations in reported PFAS lethality and adverse effects (Gebreab et al. ; Wasel et al. ). We utilized the cost-effective shallow RNA sequencing method (Atallah et al. ; Sholder et al. ; C. Ye et al. ) to analyze the expression of genes at four exposure concentrations (0.5 mg/L, 1 mg/L, 2 mg/L, and 10 mg/L) of HFPO-DA. Our results reveal overlapping sets of enrichment terms consistent across exposures, including altered expression of genes expressed in the heart and vascular tissue, suggesting cardiovascular toxicity of HFPO-DA, like its predecessor PFOA (Salimi et al. ).
To evaluate HFPO-DA toxicity, we first determined the lethal concentrations in developing zebrafish embryos. The untitrated LC50 corresponds to an estimated pH of 4.3 (Supplementary Fig. S1 and Table S1). We derived a stronger correlation of embryo survival with acidity (R2=0.80) than with the HFPO-DA concentration (R2=0.65) in untitrated HFPO-DA media. Therefore, the LC50 in untitrated HFPO-DA of 51 mg/L, which agrees with the reported LC50 of 170 µM (56 mg/L) (Satbhai et al. ), is more likely due to the low pH rather than HFPO-DA-specific exposure, highlighting the pH effect of PFAS on zebrafish embryo mortality and the need to neutralize pH in aqueous exposure experiments (Wasel et al. ).
LC50 of pH-neutralized HFPO-DA is mg/L (95% CI= mg/L) in zebrafish embryos exposed from 3 to 72 hpf. We utilized much higher concentration exposures than measured in environmental samples and occupational exposure hazards (Olsen et al. ) to establish lethal levels of HFPO-DA in zebrafish embryos and to explore differential gene expression using shallow RNA-Seq. LC50s of PFAS were reported in the thousands of milligrams per liter, including pentafluorobenzoic acid (PFBA) at 13,795 mg/L (96 hpf) (Godfrey et al. ), and PFBA and perfluorobutanesulfonic acid (PFBS) at greater than mg/L (120 hpf) (Hagenaars et al. ). Such LC50s are much higher than those of phased-out long-chain PFAS, including PFOA (473 mg/L, 96 hpf) or PFOS (70.17 mg/L, 120 hpf; 2.2 mg/L, 120 hpf) in similar zebrafish embryo studies (Ding et al. ; Godfrey et al. ; Huang et al. ), suggesting lower HFPO-DA toxic potential to zebrafish embryos than its long-chain predecessors. Furthermore, we analyzed the body burdens of embryos exposed to mg/L HFPO-DA until 72 hpf and determined a bioconcentration factor of 0.12, similar to reported low BCF values of 0.29 to 0.49 after 144 hpf zebrafish embryo exposures to 25.144.8 µM HFPO-DA (Gaballah et al. ). The low BCF value indicates that HFPO-DA does not bioaccumulate under our experimental conditions.
The incidence of malformation in zebrafish embryos was evident at nonlethal ( mg/L) to 100% lethal (20,000 mg/L) HFPO-DA exposures (Fig. ). Observed spinal deformities, edema, and hemorrhaging are common phenotypes in zebrafish developmental toxicity (Lee et al. ; Martínez et al. ) and are often reported in zebrafish PFAS exposures (Gebreab et al. ; Huang et al. ; Martínez et al. ). Spinal deformations were the dominant malformation observed in zebrafish embryos exposed to 20,000 mg/L HFPO-DA. Kyphosis at the head-trunk junction not qualified as spinal curvature may be due to developmental delay, as the development between the pectoral fin (60 hpf) and protruding mouth (72 hpf) involves a gradual straightening of the head-trunk angle (from 55° to 25°), extension of the pectoral fin, protrusion of the jaw, and decrease in yolk-size (Kimmel et al. ). Malformations were evident in all exposures above mg/L; only 12.8% of hatched embryos at mg/L exhibited malformation compared to 83.3% at mg/L. Malformations were significant in 20,000 mg/L exposures (Fig. ), and their incidence increased with higher exposure concentrations (R2=0.), indicating a positive doseresponse relationship.
Heart rate is a common co-indicator of cardiac disruption when reported with morphological effects (Craig et al. ; Kuhota et al. ). Zebrafish are an established model for human cardiac disease (den Hoed et al. ; Gierten et al. ; Milan et al. ), and their cardiac rhythm and regulation via electrical conduction are similar to those in humans (Arnaout et al. ; Gauvrit et al. ; Nemtsas et al. ). Interestingly, HBPM increased in a dose-dependent manner at 0.510 mg/L exposures, and HBPM decreased in a dose-dependent manner at mg/L (Fig. ). Tachycardia at low-level chemical exposures followed by bradycardia at higher levels has previously been observed (Han et al. ; Maeda et al. ) and may indicate a hormetic cardiac response to HFPO-DA exposure (Sampurna et al. ). Tachycardia and bradycardia can affect the regulation of cardiac muscular contractility (Søndergaard et al. ) or circulatory demand in response to respiratory and metabolic stress (Miller et al. ). Co-occurrence of pericardial edema and hemorrhaging with bradycardia at these concentrations and increased mortality from to 20,000 mg/L strongly indicate cardiovascular defects (Duan et al. ; Liu et al. ).
During normal embryo development, the transcriptome landscape is dynamic (H. Yang et al. ), with significant changes in the gene expression marking distinct stages of embryo development. To better understand the mechanisms of HFPO-DA-induced morphological and physiological effects, we utilized shallow RNA-Seq analysis. To compensate for expected false negatives due to low sequencing depth, we used NOISeq, a nonparametric tool with high sensitivity at low sequencing depth (C. R. Williams et al. ), and applied a threshold q>0.9 (equivalent to FDR<0.1). Seventy-one percent of detected DEGs were significant in only one exposure relative to control (Fig. ). Surprisingly, the highest number of DEGs was detected at the lowest exposure concentration, possibly indicating changing tolerance (Andrade et al. ) to HFPO-DA across the exposures, or a non-monotonic dose response (Z. H. Li et al. ). The ten most upregulated and downregulated genes in each exposure share functional similarities: Most of these genes are related to eye, neural, and vascular systems, metabolism/biosynthesis, gene expression regulation, and development (70%, 70%, 75%, and 80% in 0.5 mg/L, 1 mg/L, 2 mg/L, and 10 mg/L, respectively). Set A ( DEGs) and set S (38 DEGs) share GO terms (74 terms; 29.4% of set A, 55.22% of set S; Supplementary Tables S3, S4, S5, and S6) despite set S constituting only 2.4% of the total DEGs (Fig. ). Set S was further analyzed since it consists of DEGs across all exposures.
Visual sensation begins with the excitation of opsins (such as opn1mw1, opn1sw1, and opn1sw2), which activate photoreceptor-specific G-protein transducin subunits, encoded by gnat2 and gngt2b (Lagman et al. ; Tsujikawa and Malicki ). This initiation of the signaling cascade is followed by the activation of the PDE6 complex by gnat2. Zebrafish embryos are capable of shadow-induced startle response at 72 hpf once opsin expression has spread to cones (Easter and Nicola ). Furthermore, light-response hypoactivity has been reported in zebrafish exposed to 0.76 µM HFPO-DA (250 µg/L) until 120 hpf (Rericha et al. ). Downregulation of dio3a is notable, as knockdown of dio3a previously demonstrated delays in eye development through the regulation of thyroid hormone (Bagci et al. ; Heijlen et al. ; Houbrechts et al. ). Downregulation of opsin expression and PDE6 complex subunits during light sensitivity development suggests a mechanism by which HFPO-DA could disrupt visual sensory response, while the downregulation of dio3a suggests the developmental delay is responsible for the decreased expression of genes related to the visual system. Light-response assays during advanced developmental stages are needed to confirm these genotypephenotype correlations induced by HFPO-DA exposures.
Glutamate decarboxylase gad1b, which is downregulated in exposed embryos, acts downstream of the Krebs (tricarboxylic acid) cycle to produce gamma-aminobutyric acid (GABA) (Buddhala et al. ). gad1b is regularly differentially expressed when GABAergic activity is affected by chemical exposure (Filippi et al. ; Yu et al. ), and its knockdown is reported to induce craniofacial defects in zebrafish embryos (OConnor et al. ). Downregulated genes dpysl5b and nsfa are essential for axon development (Takeuchi et al. ) and the neuroendocrine system (Kurrasch et al. ; Woods et al. ), respectively. Decreased gad1b, nsfa, and dpys5b expression may indicate HFPO-DA interference with embryo neurotransmission at 72 hpf via GABA biosynthesis and neural development inhibition. Although exposures up to 26.4 mg/L HFPO-DA until 144 hpf suggested no neurodevelopmental toxicity (Gaballah et al. ), hypoactivity in dechorionated zebrafish embryos exposed to 250 µg/L HFPO-DA until 120 hpf suggests neurodevelopmental effect (Rericha et al. ).
Upregulated gene fbxl22 encodes the substrate binding subunit of SCF-E3 ligase (Hughes et al. ) responsible for the ubiquitination and regulation of sarcomeric proteins. fbxl22 overexpression induces atrophy and degradation of essential sarcomeric proteins in mouse skeletal muscle (Hughes et al. ), while knockdown in zebrafish embryos severely impairs muscle contraction (Spaich et al. ). Furthermore, fbxl22 overexpression and subsequent sarcomere disassembly have been described in cardiomyocyte regeneration at sites of injury (Beisaw et al. ). col22a1 and znfl2a are associated with the development and maintenance of zebrafish vascular systems (Qian et al. ); overexpression of col22a1 has been shown to rescue an increased vascular permeability phenotype in homozygous col22a1 mutants (Ton et al. ). col22a1 knockdown has further been shown to induce muscular dystrophy and muscle fiber detachment in zebrafish embryos (Charvet et al. ). Although the DEGs in this study provide no direct evidence for HBPM increase, the upregulation of fbxl22 may indicate cardiac stress and vascular effect via upregulation of col22a1 and znfl2a, while col22a1 upregulation may be relevant to scoliosis phenotype at to 12,000 mg/L HFPO-DA exposures. Increased HBPM at 2 mg/L and 10 mg/L HFPO-DA may be a manifestation of cardiovascular stress, but the mechanism of action is unclear without additional loss-of-function/gain-of-function experiments coupled with histological and angiographic data. Clusters of downregulated vision and neurogenesis genes and upregulated cardiovascular genes (Fig. ) suggest system-specific adverse effects of HFPO-DA exposure.
High-level exposures toxicity studies of novel chemicals or unknown mechanisms of action are necessary to determine toxicological potential, derive lethal concentration parameters, identify morphological, physiological, and molecular toxicity targets, and anticipate adverse effects during potential acute and cumulative chronic occupational and environmental exposures (Kakade et al. ). Both molecular mechanisms and the relationships between exposure concentration and toxic effects with time need to be considered to understand the toxicity of chemicals to a developing organism (Tennekes and Sánchez-Bayo ). Novel yet ubiquitous chemicals such as HFPO-DA potentially having non-specific receptor binding or involving slowly reversible binding to some receptors that do not contribute to toxicity may be time-dependent; however, their effects may also depend primarily on the exposure concentration, with time playing a minor role. Consequently, the mechanism of toxicity has important implications for risk assessment (Tennekes and Sánchez-Bayo ). Conventional toxicity testing relies on extensive observations of phenotypic endpoints in vivo. The utility of novel materials and chemicals mandates a better understanding of the morphological, physiological, genetic, and molecular targets and changes occurring in exposed biological systems.
Our experimental design has several limitations: Pooling whole embryos and larvae does not address individual variation or tissue- or cell type-specific effects, likely resulting in a loss of tissue-specific markers and organ-targeting toxicity of HFPO-DA. Nonetheless, several genes affecting visual and cardiovascular systems suggest HFPO-DA tissue-specific effects might be of further interest. While generally, there is a significant correlation between gene transcription and protein synthesis (Maier et al. ), we did not assess the HFPO-DA effects post-transcriptionally. HBPM was the only in vivo quantified physiological phenotype combined with gene expression at 0.5 mg/L, 1 mg/L, 2 mg/L, and 10 mg/L HFPO-DA. Because increased lethality, malformation, and neurodevelopmental toxicity with extended exposures to other PFAS (past 80 hpf or 96 hpf) have been reported (Gebreab et al. ; Huang et al. ; Mylroie et al. ), we recommend that future studies focus on sublethal concentration and extend the exposure time to swimming and feeding young larvae, thus allowing for behavioral assays. Histology or in situ hybridization analyses are complements to gene expression when evaluating HFPO-DA-induced organ-specific genotypephenotype correlations.
Transcriptomics allows for detecting organisms responses to environmental, chemical, and physical agents by directly measuring the molecular alterations (Kinaret et al. ; Serra et al. ). In this study, we intergraded classical in vivo developmental toxicology with toxicogenomics to the characterization of the mechanism of action (MOA) and molecular targets of HFPO-DA. We report altered HBPM, morphological changes including scoliosis and edema at lethal HFPO-DA concentrations, and effects on the expression of genes relevant to the development of nervous and cardiovascular systems in zebrafish embryos assayed from 3 to 72 hpf. While we report HFPO-DA-induced alterations at extremely high exposures that are 104- to 109-fold higher than levels detected at sites contaminated with HFPO-DA, our study identifies adverse effects, corresponding molecular targets (Alexander-Dann et al. ), and biological pathways affected by HFPO-DA during early zebrafish development. Adverse effects and altered phenotypes in this study are observed only at extremely high acute exposure concentrations and were not detected during low-level exposures (Gaballah et al. ). Our data on exposure time, dose, complex endpoint selection, and potential targets of toxicity during animal development are important to better understand and predict HFPO-DA chemical toxicity potential. To our knowledge, this is the first study to examine the effects of HFPO-DA exposure on heart physiology and gene expression through shallow RNA-Seq. As the next phase of further assessing HFPO-DA toxicity potential, we recommend longer chronic exposures at environmentally relevant concentrations and considering phenotypes and molecular targets identified in our study.
Want more information on Bf3 Gas? Feel free to contact us.
Comments
Please Join Us to post.
0